MONTREAL, QUEBEC--(Marketwire - October 04, 2007) - ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic") announced today that ProMetic has been selected by the American Society of Hematology ("ASH") to present data from its PBI-1402 clinical trial in patients with chemotherapy-induced anemia ("CIA") at its 49th Annual Meeting, being held from December 8 to 11, 2007, in Atlanta, Georgia.
